Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2014

Open Access 01-12-2014 | Research

The “graying” of infertility services: an impending revolution nobody is ready for

Authors: Norbert Gleicher, Vitaly A Kushnir, Andrea Weghofer, David H Barad

Published in: Reproductive Biology and Endocrinology | Issue 1/2014

Login to get access

Abstract

Background

As demand for infertility services by older women continues to grow, because achievable in vitro fertilization (IVF) outcomes are widely underestimated, most fertility centers do not offer maximal treatment options with use of autologous oocytes. Limited data suggest that clinical IVF outcomes in excess of what the American Society for Reproductive Medicine (ASRM) considers “futile” can, likely, be achieved up to at least age 45 years.

Methods

In an attempt to point out an evolving demographic trend in IVF, we here report our center’s IVF data for 2010-2012 and national U.S. data for 1997-2010. Though our center’s data are representative of only one IVF center’s patients, they, likely, are unique since they probably represent the most adversely selected IVF patient population ever reported and, thus, are predictive of future demographic trends. In addition we performed a systematic review of the literature on the subject based on PubMed, Medline and Google Scholar searches till year-end 2013. The literature search was performed using key words and phrases relevant to fertility treatments in older women.

Results

As demonstrated by our center’s patient demographics and national U.S. data, IVF centers are destined to treat increasingly adversely selected patients. Despite our center’s already extremely adversely selected patient population, age-specific IVF cycle outcomes in women above age 40 years, nevertheless, exceeded criteria for “futility” by the ASRM and widely quoted outcome expectations in the literature for patient ages. Age 43 discriminates between better and poorer clinical pregnancy and live birth rates.

Conclusions

“Graying” of the infertility populations in the developed world, a problem with potentially far-reaching medical and societal consequences, has so far been only insufficiently addressed in the literature. As women’s postmenopausal life spans already exceed postmenarcheal life spans at the start of the 20th century, the “graying” of infertility services can be expected to further accelerate, no longer as in recent decades bringing only women in their 40s into maternity wards but also women in their 50s and 60s. Medicine and society better get ready for this revolution.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hamilton BE, Martin JA, Sutton PD: Births: preliminary data for 2002. Natl Vital Stat Rep. 2003, 51: 1-20. Hamilton BE, Martin JA, Sutton PD: Births: preliminary data for 2002. Natl Vital Stat Rep. 2003, 51: 1-20.
2.
go back to reference Hamilton BE, Martin JA, Sutton PD: Births: preliminary data for 2003. Natl Vital Stat Rep. 2004, 53: 1-17.PubMed Hamilton BE, Martin JA, Sutton PD: Births: preliminary data for 2003. Natl Vital Stat Rep. 2004, 53: 1-17.PubMed
3.
go back to reference Bhattacharya S, Maheshwani A, Mollison J: Factors associated with failed treatment: an analysis of 121,744 women embarking on their first IVF cycles. PLoS One. 2013, 8 (12): e82249-PubMedCentralCrossRefPubMed Bhattacharya S, Maheshwani A, Mollison J: Factors associated with failed treatment: an analysis of 121,744 women embarking on their first IVF cycles. PLoS One. 2013, 8 (12): e82249-PubMedCentralCrossRefPubMed
4.
go back to reference Gleicher N, Weghofer A, Barad DH: Anti-Mūllerian hormone (AMH) defines, independent of age, low versus good-live-birth chances in women with severely diminished ovarian reserve. Fertil Steril. 2010, 94: 2824-2827.CrossRefPubMed Gleicher N, Weghofer A, Barad DH: Anti-Mūllerian hormone (AMH) defines, independent of age, low versus good-live-birth chances in women with severely diminished ovarian reserve. Fertil Steril. 2010, 94: 2824-2827.CrossRefPubMed
5.
go back to reference Weghofer A, Dietrich W, Barad DH, Gleicher N: Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Hum Reprod. 2011, 26: 1905-1909.CrossRefPubMed Weghofer A, Dietrich W, Barad DH, Gleicher N: Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Hum Reprod. 2011, 26: 1905-1909.CrossRefPubMed
6.
go back to reference Gleicher N, Ryan E, Weghofer A, Blanco-Meija S, Barad DH: Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod Biol Endocrinol. 2009, 7: 108-PubMedCentralCrossRefPubMed Gleicher N, Ryan E, Weghofer A, Blanco-Meija S, Barad DH: Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod Biol Endocrinol. 2009, 7: 108-PubMedCentralCrossRefPubMed
7.
go back to reference Niinimäki M, Suikkari AM, Mäkinen S, Söderström-Anttila V, Martikainen H: Elective single-embryo transfer in women aged 40-44 years. Hum Reprod. 2013, 28: 331-335.CrossRefPubMed Niinimäki M, Suikkari AM, Mäkinen S, Söderström-Anttila V, Martikainen H: Elective single-embryo transfer in women aged 40-44 years. Hum Reprod. 2013, 28: 331-335.CrossRefPubMed
8.
go back to reference Ethics Committee of the American Society for Reproductive Medicine 2012: Fertility treatment when the prognosis is very poor or futile: a committee opinion. Fertil Steril. 2012, 98: e6-e9.CrossRef Ethics Committee of the American Society for Reproductive Medicine 2012: Fertility treatment when the prognosis is very poor or futile: a committee opinion. Fertil Steril. 2012, 98: e6-e9.CrossRef
9.
go back to reference Barad D, Brill H, Gleicher N: Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet. 2007, 24: 629-634.PubMedCentralCrossRefPubMed Barad D, Brill H, Gleicher N: Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet. 2007, 24: 629-634.PubMedCentralCrossRefPubMed
10.
go back to reference Gleicher N, Weghofer A, Barad DH: Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation. Reprod Biomed Online. 2010, 21: 360-365.CrossRefPubMed Gleicher N, Weghofer A, Barad DH: Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation. Reprod Biomed Online. 2010, 21: 360-365.CrossRefPubMed
11.
go back to reference Gleicher N, Weghofer A, Barad DH: Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol Endocrinol. 2010, 8: 140-PubMedCentralCrossRefPubMed Gleicher N, Weghofer A, Barad DH: Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol Endocrinol. 2010, 8: 140-PubMedCentralCrossRefPubMed
12.
go back to reference Barad DH, Weghofer A, Gleicher N: Utility of age-specific serum anti-Müllerian hormone concentrations. Reprod Biomed Online. 2011, 22: 284-291.CrossRefPubMed Barad DH, Weghofer A, Gleicher N: Utility of age-specific serum anti-Müllerian hormone concentrations. Reprod Biomed Online. 2011, 22: 284-291.CrossRefPubMed
13.
go back to reference Weghofer A, Kim A, Barad DH, Gleicher N: The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation. Hum Reprod. 2012, 27: 3287-3293.CrossRefPubMed Weghofer A, Kim A, Barad DH, Gleicher N: The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation. Hum Reprod. 2012, 27: 3287-3293.CrossRefPubMed
14.
go back to reference Gleicher N, Kim A, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH: Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR). J Assist Reprod Genet. 2013, 30: 49-62.PubMedCentralCrossRefPubMed Gleicher N, Kim A, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH: Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR). J Assist Reprod Genet. 2013, 30: 49-62.PubMedCentralCrossRefPubMed
15.
go back to reference Gleicher N, Kim A, Weghofer A, Kushmir VA, Shohat-Tal A, Lazzaroni E, Lee H-J, Barad DH: Hypoandrogenism in association with diminished functional ovarian reserve. Hum Reprod. 2013, 28: 1084-1091.CrossRefPubMed Gleicher N, Kim A, Weghofer A, Kushmir VA, Shohat-Tal A, Lazzaroni E, Lee H-J, Barad DH: Hypoandrogenism in association with diminished functional ovarian reserve. Hum Reprod. 2013, 28: 1084-1091.CrossRefPubMed
16.
go back to reference Sen A, Hammes SR: Granulosa-cell specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol. 2010, 24: 1393-1403.PubMedCentralCrossRefPubMed Sen A, Hammes SR: Granulosa-cell specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol. 2010, 24: 1393-1403.PubMedCentralCrossRefPubMed
17.
go back to reference Gleicher N, Weghofer A, Barad DH: The role of androgens in follicle maturation and ovulation: friend or foe of infertility treatment?. Reprod Biol Endocrinol. 2011, 9: 116-PubMedCentralCrossRefPubMed Gleicher N, Weghofer A, Barad DH: The role of androgens in follicle maturation and ovulation: friend or foe of infertility treatment?. Reprod Biol Endocrinol. 2011, 9: 116-PubMedCentralCrossRefPubMed
18.
19.
go back to reference Gleicher N, Weghofer A, Barad DH: Low-intensity IVF: real progress?. Reprod Biomed Online. 2011, 23: 274-278.CrossRefPubMed Gleicher N, Weghofer A, Barad DH: Low-intensity IVF: real progress?. Reprod Biomed Online. 2011, 23: 274-278.CrossRefPubMed
20.
go back to reference Gleicher N, Weghofer A, Barad DH: A case-control pilot study of low-intensity IVF in good- prognosis patients. Reprod Biomed Online. 2012, 24: 396-402.CrossRefPubMed Gleicher N, Weghofer A, Barad DH: A case-control pilot study of low-intensity IVF in good- prognosis patients. Reprod Biomed Online. 2012, 24: 396-402.CrossRefPubMed
21.
go back to reference Gleicher N, Kim A, Weghofer A, Barad DH: Lessons from elective in vitro fertilization (IVF) in, principally, non-infertile women. Reprod Biol Endocrinol. 2012, 10: 48-PubMedCentralCrossRefPubMed Gleicher N, Kim A, Weghofer A, Barad DH: Lessons from elective in vitro fertilization (IVF) in, principally, non-infertile women. Reprod Biol Endocrinol. 2012, 10: 48-PubMedCentralCrossRefPubMed
22.
go back to reference Fauser BCJM, Nargund G, Nyboe Andersen A, Norman R, Tarlatzis B, Bolvin J, Ledger W: Mild ovarian stimulation for IVF: 10 years later. Hum Reprod. 2010, 25: 2678-2684.CrossRefPubMed Fauser BCJM, Nargund G, Nyboe Andersen A, Norman R, Tarlatzis B, Bolvin J, Ledger W: Mild ovarian stimulation for IVF: 10 years later. Hum Reprod. 2010, 25: 2678-2684.CrossRefPubMed
23.
go back to reference Zarek SM, Muasher SJ: Mild minimal stimulation for in vitro fertilization: an old idea that needs to be revisited. Fertil Steril. 2011, 95: 2449-2455.CrossRefPubMed Zarek SM, Muasher SJ: Mild minimal stimulation for in vitro fertilization: an old idea that needs to be revisited. Fertil Steril. 2011, 95: 2449-2455.CrossRefPubMed
24.
go back to reference Revelli A, Casano S, Salvagno F, Delle Piane L: Milder is better? Advantages and disadvantages of “mild” ovarian stimulation for human in vitro fertilization. Reprod Biol Endocrinol. 2011, 9: 25-PubMedCentralCrossRefPubMed Revelli A, Casano S, Salvagno F, Delle Piane L: Milder is better? Advantages and disadvantages of “mild” ovarian stimulation for human in vitro fertilization. Reprod Biol Endocrinol. 2011, 9: 25-PubMedCentralCrossRefPubMed
25.
go back to reference Siristatidis C, Trivella M, Chrelias C, Sioulas VD, Vrachnis N, Kassanos D: A short narrative review of the feasibility of adopting mild ovarian stimulation for IVF as the current standard of care. Arch Gynecol Obstet. 2012, 286: 505-510.CrossRefPubMed Siristatidis C, Trivella M, Chrelias C, Sioulas VD, Vrachnis N, Kassanos D: A short narrative review of the feasibility of adopting mild ovarian stimulation for IVF as the current standard of care. Arch Gynecol Obstet. 2012, 286: 505-510.CrossRefPubMed
26.
go back to reference Cedars MI: National reporting of in vitro fertilization success rates: how do we get patients useful information?. Fertil Steril. 2013, 100: 1210-1211.CrossRefPubMed Cedars MI: National reporting of in vitro fertilization success rates: how do we get patients useful information?. Fertil Steril. 2013, 100: 1210-1211.CrossRefPubMed
27.
go back to reference Gleicher N, Barad DH: A review of and commentary on the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practice. J Assist Reprod Genet. 2012, 29: 1159-1166.PubMedCentralCrossRefPubMed Gleicher N, Barad DH: A review of and commentary on the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practice. J Assist Reprod Genet. 2012, 29: 1159-1166.PubMedCentralCrossRefPubMed
28.
go back to reference Mastenbroeks S, Twisk M, van der Veen F, Repping S: Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update. 2011, 17: 454-466.CrossRef Mastenbroeks S, Twisk M, van der Veen F, Repping S: Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update. 2011, 17: 454-466.CrossRef
29.
go back to reference Pal L, Santoro N: Age-related decline in fertility. Endocrinol Metab Clin North Am. 2003, 32: 669-688.CrossRefPubMed Pal L, Santoro N: Age-related decline in fertility. Endocrinol Metab Clin North Am. 2003, 32: 669-688.CrossRefPubMed
30.
go back to reference Maheshwari A, Scotland G, Bell J, McTavish A, Hamilton M, Bhattacharya S: Direct health service costs of providing assisted reproduction services in older women. Fertil Steril. 2010, 93: 527-536.CrossRefPubMed Maheshwari A, Scotland G, Bell J, McTavish A, Hamilton M, Bhattacharya S: Direct health service costs of providing assisted reproduction services in older women. Fertil Steril. 2010, 93: 527-536.CrossRefPubMed
31.
go back to reference Practice Committee of the American Society for Reproductive Medicine: Multiple gestation associated with infertility therapy: an American Society for Reproductive Medicine Practice Committee opinion. Fertil Steril. 2012, 97: 825-834.CrossRef Practice Committee of the American Society for Reproductive Medicine: Multiple gestation associated with infertility therapy: an American Society for Reproductive Medicine Practice Committee opinion. Fertil Steril. 2012, 97: 825-834.CrossRef
32.
go back to reference Martin JA, Hamilton BE, Osterman MJ: Three decades of twin births in the United States, 1980-2009. NCHS Data Brief. 2012, 80: 1-8.PubMed Martin JA, Hamilton BE, Osterman MJ: Three decades of twin births in the United States, 1980-2009. NCHS Data Brief. 2012, 80: 1-8.PubMed
33.
go back to reference Bamberg C, Fotopoulou C, Neissner P, Slowinski T, Dudenhausen JW, Proquitte H, Bührer C, Henrich W: Maternal characteristics and twin gestation outcomes over 10 years: impact of conception methods. Fertil Steril. 2012, 98: 95-101.CrossRefPubMed Bamberg C, Fotopoulou C, Neissner P, Slowinski T, Dudenhausen JW, Proquitte H, Bührer C, Henrich W: Maternal characteristics and twin gestation outcomes over 10 years: impact of conception methods. Fertil Steril. 2012, 98: 95-101.CrossRefPubMed
34.
go back to reference Gleicher N, Campbell DP, Chan CL, Karande V, Rao R, Balin M, Pratt D: The desire for multiple births in couples with infertility problems contradicts present practice patterns. Hum Reprod. 1995, 10: 1079-1084.PubMed Gleicher N, Campbell DP, Chan CL, Karande V, Rao R, Balin M, Pratt D: The desire for multiple births in couples with infertility problems contradicts present practice patterns. Hum Reprod. 1995, 10: 1079-1084.PubMed
35.
go back to reference Hourvitz A, Machtinger R, Maman E, Baum M, Dor J, Levron J: Assisted reproduction in women over 40 years of age: how old is too old?. Reprod Biomed Online. 2009, 19: 599-603.CrossRefPubMed Hourvitz A, Machtinger R, Maman E, Baum M, Dor J, Levron J: Assisted reproduction in women over 40 years of age: how old is too old?. Reprod Biomed Online. 2009, 19: 599-603.CrossRefPubMed
36.
go back to reference Marinakis G, Nikolaou D: What is the role of assisted reproductive technology in the management of age-related infertility?. Hum Fertil (Camb). 2011, 14: 8-15.CrossRef Marinakis G, Nikolaou D: What is the role of assisted reproductive technology in the management of age-related infertility?. Hum Fertil (Camb). 2011, 14: 8-15.CrossRef
40.
go back to reference Klemetti R, Gissler M, Sevón T, Hemminki E: Resource allocation of in vitro fertilization: a nationwide register-based cohort study. BMC Health Service Res. 2007, 7: 210-CrossRef Klemetti R, Gissler M, Sevón T, Hemminki E: Resource allocation of in vitro fertilization: a nationwide register-based cohort study. BMC Health Service Res. 2007, 7: 210-CrossRef
41.
go back to reference Zanini G: Abandoned by the State, betrayed by the Church: Italian experiences of cross-border reproductive care. Reprod Biomed Online. 2011, 23: 565-572.CrossRefPubMed Zanini G: Abandoned by the State, betrayed by the Church: Italian experiences of cross-border reproductive care. Reprod Biomed Online. 2011, 23: 565-572.CrossRefPubMed
42.
go back to reference Inhorn MC, Patrizio P: The global landscape of cross-border reproductive care: twenty key findings for the new millennium. Curr Opin Obstet Gynecol. 2012, 24: 158-163.CrossRefPubMed Inhorn MC, Patrizio P: The global landscape of cross-border reproductive care: twenty key findings for the new millennium. Curr Opin Obstet Gynecol. 2012, 24: 158-163.CrossRefPubMed
44.
45.
go back to reference Tsafrir A, Simon A, Margalioth EJ, Laufer N: What should be the first-line treatment for unexplained infertility in women over 40 years of age-ovulation induction and IUI, or IVF?. Reprod Biomed Online. 2009, 19 (Suppl 4): 4334-PubMed Tsafrir A, Simon A, Margalioth EJ, Laufer N: What should be the first-line treatment for unexplained infertility in women over 40 years of age-ovulation induction and IUI, or IVF?. Reprod Biomed Online. 2009, 19 (Suppl 4): 4334-PubMed
46.
go back to reference Connoly MP, Hoorens S, Chambers GM, on behalf of the ESHRE Reproduction and Society Task Force: The costs and consequences of assisted reproductive technology on economic perspectives. Hum Reprod Update. 2010, 16: 603-613.CrossRef Connoly MP, Hoorens S, Chambers GM, on behalf of the ESHRE Reproduction and Society Task Force: The costs and consequences of assisted reproductive technology on economic perspectives. Hum Reprod Update. 2010, 16: 603-613.CrossRef
47.
go back to reference HR. 4773, Pub L No. 102-493, Fertility Clinic Success Rate and Certification Act of 1992, 102 Cong (1991-1992), ENR, HR. 4773, Pub L No. 102-493, Fertility Clinic Success Rate and Certification Act of 1992, 102 Cong (1991-1992), ENR,
48.
go back to reference Kushnir VA, Vidali A, Barad DH, Gleicher N: The status of public reporting of clinical outcomes in assisted reproductive technology (ART). Fertil Steril. 2013, 100: 736-741.CrossRefPubMed Kushnir VA, Vidali A, Barad DH, Gleicher N: The status of public reporting of clinical outcomes in assisted reproductive technology (ART). Fertil Steril. 2013, 100: 736-741.CrossRefPubMed
49.
go back to reference Scott RT, Upham KM, Forman EJ, Hong KH, Scott KL, Taylor D, Tao X, Treff NR: Blastocyst biopsy with comprehensive chromosomal screening and fresh embryo transfer significantly increasing in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril. 2013, 100: 697-703.CrossRefPubMed Scott RT, Upham KM, Forman EJ, Hong KH, Scott KL, Taylor D, Tao X, Treff NR: Blastocyst biopsy with comprehensive chromosomal screening and fresh embryo transfer significantly increasing in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril. 2013, 100: 697-703.CrossRefPubMed
50.
go back to reference Spandorfer SD, Bendikson K, Dragisic K, Schattman G, Davis OK, Rosenwaks Z: Outcome of in vitro fertilization in women 45 years and older who use autologous oocytes. Fertil Steril. 2007, 87: 74-76.CrossRefPubMed Spandorfer SD, Bendikson K, Dragisic K, Schattman G, Davis OK, Rosenwaks Z: Outcome of in vitro fertilization in women 45 years and older who use autologous oocytes. Fertil Steril. 2007, 87: 74-76.CrossRefPubMed
51.
go back to reference Schimberni M, Morgia F, Colabianchi J, Giallonardo A, Piscitelli C, Giannini P, Montigianini M, Sbracia M: Natural-cycle in vitro fertilization in po0r responder patients: a survey of 400 consecutive cycles. Fertil Steril. 2009, 92: 1297-1301.CrossRefPubMed Schimberni M, Morgia F, Colabianchi J, Giallonardo A, Piscitelli C, Giannini P, Montigianini M, Sbracia M: Natural-cycle in vitro fertilization in po0r responder patients: a survey of 400 consecutive cycles. Fertil Steril. 2009, 92: 1297-1301.CrossRefPubMed
52.
go back to reference Liu K, Reproductive Endocrinology and Infertility Committee; Family Physician Advisory Committee; Maternal-Fetal Medicine Committee; Executive and Council of the Society of Obstetricians: Case A. Advanced reproductive age and infertility. J Obstet Gynecol Can. 2011, 33: 1165-1175. Liu K, Reproductive Endocrinology and Infertility Committee; Family Physician Advisory Committee; Maternal-Fetal Medicine Committee; Executive and Council of the Society of Obstetricians: Case A. Advanced reproductive age and infertility. J Obstet Gynecol Can. 2011, 33: 1165-1175.
53.
go back to reference Soullier N, Bouyer J, Pouly JL, Guibert J, de La Rochebrochard E: Effect of the woman’s age on discontinuation of IVF treatment. Reprod Biomed Online. Soullier N, Bouyer J, Pouly JL, Guibert J, de La Rochebrochard E: Effect of the woman’s age on discontinuation of IVF treatment. Reprod Biomed Online.
54.
go back to reference Lawlor DA, Nelson SM: Effect of age on decisions about the number of embryos to transfer in assisted conception: a prospective study. Lancet. 2012, 379: 521-527. Erratum Lancet 2012, 379:894CrossRefPubMed Lawlor DA, Nelson SM: Effect of age on decisions about the number of embryos to transfer in assisted conception: a prospective study. Lancet. 2012, 379: 521-527. Erratum Lancet 2012, 379:894CrossRefPubMed
55.
go back to reference Jean M, Tessier P, Bonnaud-Antignac A, Freour T, Barriere P, Dabouis G: Is the debate about single or double embryo transfer following in vitro fertilization really an ethical dilemma?. Clin Ethics. 2013, 8: 61-69.CrossRef Jean M, Tessier P, Bonnaud-Antignac A, Freour T, Barriere P, Dabouis G: Is the debate about single or double embryo transfer following in vitro fertilization really an ethical dilemma?. Clin Ethics. 2013, 8: 61-69.CrossRef
56.
go back to reference Gleicher N: Strategies to improve insurance coverage for infertility services. Fertil Steril. 1998, 70: 1006-1008.CrossRefPubMed Gleicher N: Strategies to improve insurance coverage for infertility services. Fertil Steril. 1998, 70: 1006-1008.CrossRefPubMed
59.
go back to reference Collins JA: An international survey of the health economics of IVF and ICSI. Hum Reprod Update. 2002, 8: 265-277.CrossRefPubMed Collins JA: An international survey of the health economics of IVF and ICSI. Hum Reprod Update. 2002, 8: 265-277.CrossRefPubMed
60.
go back to reference Kraft D: Where families are priced, help is free. The New York Times. 2012 Kraft D: Where families are priced, help is free. The New York Times. 2012
61.
go back to reference Bissonnette F, Phillips SJ, Gunby J, Holzer H, Mahutte N, St-Michel P, Kadoch IJ: Working to eliminate multiple pregnancies: a success story in Québec. Reprod Biomed Online. 2011, 23: 500-504.CrossRefPubMed Bissonnette F, Phillips SJ, Gunby J, Holzer H, Mahutte N, St-Michel P, Kadoch IJ: Working to eliminate multiple pregnancies: a success story in Québec. Reprod Biomed Online. 2011, 23: 500-504.CrossRefPubMed
62.
go back to reference Gleicher N: Eliminating multiple pregnancies: an appropriate target for government intervention?. Reprod Biomed Online. 2011, 23: 401-406.CrossRef Gleicher N: Eliminating multiple pregnancies: an appropriate target for government intervention?. Reprod Biomed Online. 2011, 23: 401-406.CrossRef
64.
go back to reference Perla L: Is in-vitro fertilization for older women ethical?. Personal Perspective Nurs Ethics. 2001, 8: 152-158.CrossRefPubMed Perla L: Is in-vitro fertilization for older women ethical?. Personal Perspective Nurs Ethics. 2001, 8: 152-158.CrossRefPubMed
66.
go back to reference Mac Dougal K, Beyene Y, Nachtigall RD: Age shock: misperceptions of the impact of age on fertility before and after IVF in women who conceive after age 40. Hum Reprod. 2013, 28: 350-356.CrossRef Mac Dougal K, Beyene Y, Nachtigall RD: Age shock: misperceptions of the impact of age on fertility before and after IVF in women who conceive after age 40. Hum Reprod. 2013, 28: 350-356.CrossRef
67.
go back to reference O’Reilly-Green C, Cohen WR: Pregnancy in women aged 40 and older. Obstet Gynecol Clin North Am. 1993, 20: 313-331.PubMed O’Reilly-Green C, Cohen WR: Pregnancy in women aged 40 and older. Obstet Gynecol Clin North Am. 1993, 20: 313-331.PubMed
68.
go back to reference Gleicher N, Vidali A, Karande V: The immunological “Wars of the Roses”: disagreements amongst reproductive immunologists. Hum Reprod. 2002, 17: 539-542.CrossRefPubMed Gleicher N, Vidali A, Karande V: The immunological “Wars of the Roses”: disagreements amongst reproductive immunologists. Hum Reprod. 2002, 17: 539-542.CrossRefPubMed
69.
go back to reference Sen A, Kushnir VA, Barad DH, Gleicher N: Endocrine autoimmune diseases and female infertility. Nat Rev Endocrinol. 2014, 10: 37-50.CrossRefPubMed Sen A, Kushnir VA, Barad DH, Gleicher N: Endocrine autoimmune diseases and female infertility. Nat Rev Endocrinol. 2014, 10: 37-50.CrossRefPubMed
70.
go back to reference Leary PJ, Leary SES, Stout KK, Schwartz SM, Easterling TR: Maternal, perinatal and postneonatal outcomes in women with chronic heart disease in Washington State. Obstet Gynecol. 2012, 120: 1283-1290.PubMedCentralPubMed Leary PJ, Leary SES, Stout KK, Schwartz SM, Easterling TR: Maternal, perinatal and postneonatal outcomes in women with chronic heart disease in Washington State. Obstet Gynecol. 2012, 120: 1283-1290.PubMedCentralPubMed
71.
go back to reference Lamminpää R, Vehviläinen-Julkunen K, Gissler M, Heinonen S: Preeclampsia complicated by advanced maternal age:a registry-based study on primiparous women in Finland 1997-2008. BMC Pregnancy Childbirth. 2012, 12: 47-PubMedCentralCrossRefPubMed Lamminpää R, Vehviläinen-Julkunen K, Gissler M, Heinonen S: Preeclampsia complicated by advanced maternal age:a registry-based study on primiparous women in Finland 1997-2008. BMC Pregnancy Childbirth. 2012, 12: 47-PubMedCentralCrossRefPubMed
72.
go back to reference Kort DH, Gosselin J, Choi JM, Thornton MH, Cleary-Goldman J, Suaer MV: Pregnancy after age 50: defining risks for mother and child. Am J Perinat. 2012, 29: 245-250.CrossRef Kort DH, Gosselin J, Choi JM, Thornton MH, Cleary-Goldman J, Suaer MV: Pregnancy after age 50: defining risks for mother and child. Am J Perinat. 2012, 29: 245-250.CrossRef
73.
go back to reference Le Ray C, Scherier S, Anselem O, Marszalek A, Tsatsaris V, Cabrol D, Goffinet F: Association between oocyte donation and maternal and perinatal outcomes in women aged 43 years and older. Hum Reprod. 2012, 27: 896-8901.CrossRefPubMed Le Ray C, Scherier S, Anselem O, Marszalek A, Tsatsaris V, Cabrol D, Goffinet F: Association between oocyte donation and maternal and perinatal outcomes in women aged 43 years and older. Hum Reprod. 2012, 27: 896-8901.CrossRefPubMed
74.
go back to reference Olivienne F: Avoiding multiple pregnancies. Double trouble: yes as pregnancy is an adverse outcome. Hum Reprod. 2000, 15: 1663-1665.CrossRef Olivienne F: Avoiding multiple pregnancies. Double trouble: yes as pregnancy is an adverse outcome. Hum Reprod. 2000, 15: 1663-1665.CrossRef
75.
go back to reference Land JA, Evers JL: Risks and complications in assisted reproduction techniques: report of an ESHRE consensus meeting. Hum Reprod. 2003, 18: 455-457.CrossRefPubMed Land JA, Evers JL: Risks and complications in assisted reproduction techniques: report of an ESHRE consensus meeting. Hum Reprod. 2003, 18: 455-457.CrossRefPubMed
76.
go back to reference Kulkarni AD, Jamieson DJ, Jones HW, Kissin DM, Gallo MF, Macaluso M, Adashi EY: Fertility treatments and multiple births in the United States. N Engl J Med. 2013, 369: 2218-2225.CrossRefPubMed Kulkarni AD, Jamieson DJ, Jones HW, Kissin DM, Gallo MF, Macaluso M, Adashi EY: Fertility treatments and multiple births in the United States. N Engl J Med. 2013, 369: 2218-2225.CrossRefPubMed
77.
go back to reference Gleicher N: The irrational attraction of elective single-embryo transfer (eSET). Hum Reprod. 2013, 28: 294-297.CrossRefPubMed Gleicher N: The irrational attraction of elective single-embryo transfer (eSET). Hum Reprod. 2013, 28: 294-297.CrossRefPubMed
78.
go back to reference Scotland GS, MvNamee P, Peddle VL, Bhattacharya S: Safety versus success in elective single embryo transfer: women’s preference for outcomes of in vitro fertilization. BJOG. 2007, 114: 977-983.CrossRefPubMed Scotland GS, MvNamee P, Peddle VL, Bhattacharya S: Safety versus success in elective single embryo transfer: women’s preference for outcomes of in vitro fertilization. BJOG. 2007, 114: 977-983.CrossRefPubMed
79.
go back to reference Kita K, Watanabe T, Ohsaka K, Hayashi H, Kubota Y, Nagashima A, Aoki I, Taniguchi H, Noce T, Inoue K, Miki H, Ogonuki N, Tanaka H, Ogura A, Ogawa T: Production of functional spermatids from mouse germline stem cells in ectopically reconstituted seminiferous tubules. Biol Reprod. 2007, 76: 211-217.CrossRefPubMed Kita K, Watanabe T, Ohsaka K, Hayashi H, Kubota Y, Nagashima A, Aoki I, Taniguchi H, Noce T, Inoue K, Miki H, Ogonuki N, Tanaka H, Ogura A, Ogawa T: Production of functional spermatids from mouse germline stem cells in ectopically reconstituted seminiferous tubules. Biol Reprod. 2007, 76: 211-217.CrossRefPubMed
80.
go back to reference White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL: Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med. 2012, 18: 413-421.PubMedCentralCrossRefPubMed White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL: Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med. 2012, 18: 413-421.PubMedCentralCrossRefPubMed
81.
go back to reference Hayashi K, Ohta H, Kurimoto K, Aramaki S, Saitou M: Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell. 2011, 146: 519-532.CrossRefPubMed Hayashi K, Ohta H, Kurimoto K, Aramaki S, Saitou M: Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell. 2011, 146: 519-532.CrossRefPubMed
82.
go back to reference Hayashi K, Ogushi S, Kurimoto K, Shimamoto S, Ohta H, Saitou M: Offspring from oocyte derived from in vitro primordial germ cell-like cells in mice. Science. 2012, 338: 971-975.CrossRefPubMed Hayashi K, Ogushi S, Kurimoto K, Shimamoto S, Ohta H, Saitou M: Offspring from oocyte derived from in vitro primordial germ cell-like cells in mice. Science. 2012, 338: 971-975.CrossRefPubMed
Metadata
Title
The “graying” of infertility services: an impending revolution nobody is ready for
Authors
Norbert Gleicher
Vitaly A Kushnir
Andrea Weghofer
David H Barad
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2014
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-12-63

Other articles of this Issue 1/2014

Reproductive Biology and Endocrinology 1/2014 Go to the issue